Tenon Medical Inc TNON shares are trading higher by 49% to $1.27 Friday morning after the company announced it has successfully passed a recent FDA Quality System Inspection Technique (QSIT) Level 2 Inspection.
This inspection assesses compliance with Quality System Requirements and related regulations for medical device manufacturers. The FDA inspector found no violations or objectionable conditions during the inspection, and no FDA Form 483 was issued.
Tenon Medical's CEO, Steve Foster, commended the company's dedication to maintaining a high-quality system and recognized their operational and regulatory teams for their diligence.
See Also: Former FTX CEO Sam Bankman-Fried Found Guilty On All Criminal Fraud Charges
According to data from Benzinga Pro, TNON has a 52-week high of $31.10 and a 52-week low of $0.77.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
